Key points are not available for this paper at this time.
Collectively, our results show that LNP-mediated delivery of pDNA is a suitable method to engineer human T cells to express CAR, which holds promise for improving the production methods and broader application of this therapy in the future.
Prazeres et al. (Sun,) studied this question.